Literature DB >> 10611618

Resampling-based methods for the analysis of multiple endpoints in clinical trials.

P Reitmeir1, G Wassmer.   

Abstract

We consider multivariate tests for comparing two treatments with multiple endpoints. The test decision is drawn from the simultaneous consideration of the univariate tests for the single endpoints. A general class of these tests, called cut-off tests, can be given, which, however, can lead to highly conservative procedures because the dependencies among the endpoints are not taken into account. In applying resampling-based methods considerable improvements for these tests can be achieved. Resampling-based cut-off tests are proposed which are sensitive against a treatment difference in a single endpoint, in a subgroup of endpoints, or in all endpoints. The results of Monte Carlo simulations demonstrate that a remarkable gain in statistical power as compared to the crude simultaneous consideration can be reached. In particular, for the multivariate one-sided test situation the proposed tests can be recommended. As an example the application of the tests is demonstrated by data from a clinical trial. Copyright 1999 John Wiley & Sons, Ltd.

Mesh:

Year:  1999        PMID: 10611618     DOI: 10.1002/(sici)1097-0258(19991230)18:24<3453::aid-sim283>3.0.co;2-z

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  2 in total

1.  Low antibodies against Plasmodium falciparum and imbalanced pro-inflammatory cytokines are associated with severe malaria in Mozambican children: a case-control study.

Authors:  Eduard Rovira-Vallbona; Gemma Moncunill; Quique Bassat; Ruth Aguilar; Sonia Machevo; Laura Puyol; Llorenç Quintó; Clara Menéndez; Chetan E Chitnis; Pedro L Alonso; Carlota Dobaño; Alfredo Mayor
Journal:  Malar J       Date:  2012-05-30       Impact factor: 2.979

2.  Methods to adjust for multiple comparisons in the analysis and sample size calculation of randomised controlled trials with multiple primary outcomes.

Authors:  Victoria Vickerstaff; Rumana Z Omar; Gareth Ambler
Journal:  BMC Med Res Methodol       Date:  2019-06-21       Impact factor: 4.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.